Literature DB >> 19578742

Cholangiocarcinomas associated with long-term inflammation express the activation-induced cytidine deaminase and germinal center-associated nuclear protein involved in immunoglobulin V-region diversification.

Waraporn Chan-On1, Kazuhiko Kuwahara, Naoya Kobayashi, Kazutaka Ohta, Tatsuya Shimasaki, Banchob Sripa, Chanvit Leelayuwat, Nobuo Sakaguchi.   

Abstract

Cholangiocarcinoma (CCA) represents a model of tumor development after long-term inflammation which causes DNA damage or impairs DNA repair mechanism. AID and GANP, both appearing in antigen-driven B cells, are involved in affinity maturation of the immunoglobulin V-region with increased somatic mutation. A normal cholangiocyte line showed the induction of AID transcripts after stimulation with TNF-alpha, whereas ganp transcripts appeared constitutively in this cell line. Next, we examined the expression of AID and GANP in clinical CCA specimens to obtain information whether their expression levels are associated with the malignant grade of CCA. AID expression was similarly detected in the clinical cases of both well-differentiated and poorly-differentiated CCAs. On the contrary, GANP expression was detected in CCA cells at a higher level in the nucleus of poorly-differentiated CCAs with shorter survivals than in that of well-differentiated CCAs. The high and low cases of nuclear GANP expression showed no change in the frequency of the TP53 mutations, however, further investigation by in vitro experiment demonstrated that the high GANP expression caused the increased number of gammaH2AX foci after DNA damage by ionizing-irradiation. These results suggest that GANP is involved in regulation of DNA repair mechanism and the abnormal over-expression of GANP together with AID might be associated with rigorous DNA damage, potentially causing the malignant development of CCAs during long-term inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19578742

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  6 in total

1.  Surgical Management of Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Impact of Lymphadenectomy on Peri-Operative Outcomes.

Authors:  Fabio Bagante; Gaya Spolverato; Matthew Weiss; Sorin Alexandrescu; Hugo P Marques; Luca Aldrighetti; Shishir K Maithel; Carlo Pulitano; Todd W Bauer; Feng Shen; George A Poultsides; Olivier Soubrane; Guillaume Martel; B Groot Koerkamp; Alfredo Guglielmi; Endo Itaru; Andrea Ruzzenente; Timothy M Pawlik
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352

2.  TP53 mutations coincide with the ectopic expression of activation-induced cytidine deaminase in the fibroblast-like synoviocytes derived from a fraction of patients with rheumatoid arthritis.

Authors:  H Igarashi; J Hashimoto; T Tomita; H Yoshikawa; K Ishihara
Journal:  Clin Exp Immunol       Date:  2010-05-10       Impact factor: 4.330

3.  Increased chemosensitivity via BRCA2-independent DNA damage in DSS1- and PCID2-depleted breast carcinomas.

Authors:  Naomi Gondo; Yasuhiro Sakai; Zhenhuan Zhang; Yukari Hato; Kiyotaka Kuzushima; Suchada Phimsen; Yoshiaki Kawashima; Makoto Kuroda; Motoshi Suzuki; Seiji Okada; Hiroji Iwata; Tatsuya Toyama; Andri Rezano; Kazuhiko Kuwahara
Journal:  Lab Invest       Date:  2021-05-24       Impact factor: 5.502

Review 4.  Mutational signatures and processes in hepatobiliary cancers.

Authors:  Ekaterina Zhuravleva; Colm J O'Rourke; Jesper B Andersen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-03-10       Impact factor: 73.082

5.  Patterns and genomic correlates of PD-L1 expression in patients with biliary tract cancers.

Authors:  Kabir Mody; Jason Starr; Michelle Saul; Kelsey Poorman; Benjamin A Weinberg; Mohamed E Salem; Ari VanderWalde; Anthony F Shields
Journal:  J Gastrointest Oncol       Date:  2019-12

6.  GANP protein encoded on human chromosome 21/mouse chromosome 10 is associated with resistance to mammary tumor development.

Authors:  Kazuhiko Kuwahara; Mutsuko Yamamoto-Ibusuki; Zhenhuan Zhang; Suchada Phimsen; Naomi Gondo; Hiroko Yamashita; Toru Takeo; Naomi Nakagata; Daisuke Yamashita; Yoshimi Fukushima; Yutaka Yamamoto; Hiroji Iwata; Hideyuki Saya; Eisaku Kondo; Keitaro Matsuo; Motohiro Takeya; Hirotaka Iwase; Nobuo Sakaguchi
Journal:  Cancer Sci       Date:  2016-02-09       Impact factor: 6.716

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.